- Home
- MIST vs PSNL Comparison
MIST vs PSNL Comparison
Compare MIST & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | PSNL |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 729.1M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MIST | PSNL |
|---|---|---|
| Price | $1.53 | $6.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $8.00 | ★ $12.20 |
| AVG Volume (30 Days) | 1.4M | ★ 2.3M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | $2,915.14 | $15.34 |
| Revenue Next Year | N/A | $41.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $3.84 |
| 52 Week High | $3.06 | $11.50 |
Technical Indicators
Market Signals| Indicator | MIST | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 35.68 | 54.49 |
| Support Level | $1.40 | $5.81 |
| Resistance Level | $2.01 | $7.04 |
| Average True Range (ATR) | 0.12 | 0.50 |
| MACD | -0.05 | 0.14 |
| Stochastic Oscillator | 10.91 | 65.23 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.